Clinical findings and genetic analysis of the patients with IL-12R beta 1 deficiency from southeast Turkey


Creative Commons License

DOĞRUEL D., ÖZGÜR GÜNDEŞLİOĞLU Ö., YILMAZ M., Alabaz D., ALTINTAŞ D. U., KOCABAŞ E.

TURKISH JOURNAL OF PEDIATRICS, cilt.61, sa.2, ss.174-179, 2019 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 61 Sayı: 2
  • Basım Tarihi: 2019
  • Doi Numarası: 10.24953/turkjped.2019.02.004
  • Dergi Adı: TURKISH JOURNAL OF PEDIATRICS
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.174-179
  • Çukurova Üniversitesi Adresli: Evet

Özet

IL-12R beta 1 deficiency is an autosomal recessive disorder characterized by predisposition to poorly pathogenic mycobacteria, salmonella and candida species. We aimed to analyze the clinical manifestations, immunological and genetic features of IL-12R beta 1 deficiency in 10 Turkish patients from a single center. We retrospectively studied the clinical manifestations and genetic analysis of the IL-12R beta 1 deficiency patients from 2008 to 2016. Ten patients were diagnosed and followed for eight years. The mean age at onset and diagnosis were 24.1 +/- 42.5 (med:10.5) and 52.3 +/- 6.83 (med:20) months, respectively. Parental consanguinity rate was 81.8%. All patients were BCG vaccinated. Abscess and axillary lymphadenopathy in the vaccinated area was the most common initial presentation following the BCG vaccination, six patients had recurring oral candidiasis. Active infections were treated appropriately, in addition to prophylactic therapy with IFN.. We identified 6 different mutations in the IL12RB1 gene in 10 patients including 5 splice-site mutations, 3 missense, 1 frameshift, 1 premature stop codon. One of these mutations was novel. The most common mutation was IVS8+1G>A(c.783+1G>A) followed by p.R175W(c.523C>T). This study emphasizes that patients presented with abscess and axillary lymphadenopathy associated with BCG vaccination should be evaluated for IL-12R beta 1 deficiency.